Clinical Trial Update: A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1-2 study of ST101 in patients with advanced solid tumors, including glioblastoma and melanoma. The trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Glioblastoma
• Melanoma
• Prostate Cancer

Drugs mentioned

• ST101 (ST101)

Snippet

Sponsor: Sapience Therapeutics | Conditions: Glioblastoma, Melanoma Stage IV | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING